ChemicalBook > CAS DataBase List > YC-1

YC-1

YC-1 Structure
YC-1
  • CAS No.170632-47-0
  • Chemical Name:YC-1
  • CBNumber:CB2395371
  • Molecular Formula:C19H16N2O2
  • Formula Weight:304.34
  • MOL File:170632-47-0.mol
YC-1 Property
  • Melting point 110-112℃
  • Boiling point 522.2±50.0 °C(Predicted)
  • Density 1.24±0.1 g/cm3(Predicted)
  • storage temp. Sealed in dry,Room Temperature
  • solubility DMSO: 12 mg/mL
  • pka 13.83±0.10(Predicted)
  • form solid
  • color white
  • Stability Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months.
  • FDA UNII 515CC1WPTE
  • UNSPSC Code 41106305
  • NACRES NA.77
Safety
  • WGK Germany  :3
Hazard and Precautionary Statements (GHS)
  • Symbol(GHS)
  • Signal wordWarning
  • Hazard statements H302-H315-H319-H335
  • Precautionary statements P261-P305+P351+P338
YC-1 Price More Price(3)
  • Brand: Sigma-Aldrich(India)
  • Product number: Y102
  • Product name : YC-1
  • Purity: powder
  • Packaging: 5MG
  • Price: ₹20080.38
  • Updated: 2022/06/14
  • Buy: Buy
  • Brand: Sigma-Aldrich(India)
  • Product number: Y102
  • Product name : YC-1
  • Purity: powder
  • Packaging: 25MG
  • Price: ₹71878
  • Updated: 2022/06/14
  • Buy: Buy
  • Brand: Sigma-Aldrich(India)
  • Product number: 688100
  • Product name : YC-1 - CAS 170632-47-0 - Calbiochem
  • Purity: A nitric oxide-independent, superoxide-sensitive activator of soluble guanylyl cyclase.
  • Packaging: 5MG
  • Price: ₹23550
  • Updated: 2022/06/14
  • Buy: Buy

YC-1 Chemical Properties,Usage,Production

  • Description YC-1 (170632-47-0) is a nitric oxide-independent activator of soluble guanylyl cyclase (sGC). Significantly elevates cGMP levels and inhibits collagen-stimulated aggregation of rabbit platelets (IC50?= 14.6 μM).1?Induces human endometrial cancer cell senescence via modulation of HIF1α activity.2?Induces degradation of HIF1α.3?Protects against glutamate-induced neuronal damage4?and β-amyloid-induced toxicity in differentiated PC12 cells5.
  • Uses YC-1 has been used as a hypoxia-inducible factor 1α (HIF-1α) inhibitor:
    • to reduce hypoxia induced Jagged1 expression in cardiomyocytes (CMs)
    • to study its effect on progenitor expansion and CD34+ and side population (SP) cell phenotype and on the proliferation rate of cells with an ability to form long term colony forming units
    • to study its effect on regulating sphingosine 1-phosphate (S1P) bound to albumin induced plasminogen activator inhibitor 1 (PAI-1) expression by activating Rho/ Rho-associated protein kinase (ROCK) pathway.

  • Definition ChEBI: Lificiguat is a member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation. It has a role as an antineoplastic agent, a soluble guanylate cyclase activator, an apoptosis inducer, a platelet aggregation inhibitor and a vasodilator agent. It is a member of indazoles, a member of furans and an aromatic primary alcohol.
  • General Description A nitric oxide-independent, superoxide-sensitive activator of soluble guanylyl cyclase. Inhibits platelet adhesion to collagen and acts as an antithrombotic agent. Reported to reduce HIF-1α levels and xenograft growth.
  • Biochem/physiol Actions YC-1 activates soluble guanylyl cyclase and prevents platelet aggregation and vascular contraction. It has a potential to treat circulation disorders. YC-1 also has an ability to inhibit hypoxia-inducible factor 1α (HIF-1α) activity in vitro. It acts as a potential antiangiogenic anticancer agent.
  • storage +4°C
  • References 1) Martin?et al.?(2001),?YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components;?Proc. Natl. Acad. Sci. USA,?98?12938 2) Kato?et al.?(2006),?Induction of human endometrial cancer cell senescence through modulation of HIF-1alpha activity by EGLN1; Int. J. Cancer,?118?1144 3) Kim?et al.?(2006),?A domain responsible for HIF-1alpha degradation by YC-1, a novel anticancer agent; Int. J. Oncol.,?29?255 4) Tai?et al. (2018),?Therapeutic window for YC-1 following glutamate-induced neuronal damage and transient focal cerebral ischemia; Mol. Med. Rep.,?17?6490 5) Tsai?et al.?(2013),?The role of heat shock protein 70 in the protective effect of YC-1 on β-amyloid-induced toxicity in differentiated PC12 cells.; PLoS One,?8(7)?e69320
YC-1 Preparation Products And Raw materials
Raw materials
Preparation Products
Global(141)Suppliers
  • Supplier:
    Alchem Pharmtech,Inc.
  • Tel:8485655694
  • Email:sales@alchempharmtech.com
  • Country:United States
  • ProdList:63687
  • Advantage:58
  • Supplier:
    TargetMol Chemicals Inc.
  • Tel:+1-781-999-5354<br/>+1-00000000000
  • Email:marketing@targetmol.com
  • Country:United States
  • ProdList:32159
  • Advantage:58
  • Supplier:
    InvivoChem
  • Tel:+1-708-310-1919<br/>+1-13798911105
  • Email:sales@invivochem.cn
  • Country:United States
  • ProdList:6391
  • Advantage:58
  • Supplier:
    TargetMol Chemicals Inc.
  • Tel:
  • Email:support@targetmol.com
  • Country:United States
  • ProdList:38630
  • Advantage:58
YC-1 Spectrum
170632-47-0, YC-1Related Search:
  • 化学试剂
  • 抑制剂
  • 药靶配体
  • 合成有机化合物配体
  • Guanylyl Cyclase Activators
  • G Proteins and Cyclic Nucleotides
  • Cyclic Nucleotide Metabolism
  • BioChemical
  • Cell Biology
  • Cell Signaling and Neuroscience
  • C19H16N2O2
  • 利非西呱,10 MM DMSO 溶液
  • YC-1,GUANYLYL CYCLASE活化剂
  • YC-1,胍基环化酶激活剂
  • (5-(1-苄基-1H-吲唑-3-基)呋喃-2-基)甲醇
  • 3-(5'-羟基甲基-2'-呋喃基)-1-苯基吲哚
  • 利非西呱
  • 170632-47-0
  • Lificiguat, 10 mM in DMSO
  • YC-1, guanylyl cyclase activator
  • YC-1(Lificiguat)
  • CS-2261
  • YC-1 - CAS 170632-47-0 - Calbiochem
  • 1-benzyl-3-(5-hydroxymethyl-2-furyl)indazole
  • YC-1 (3-(5'-HYDROXYMETHYL-2'-FURYL)-1-BE NZYL INDAZOLE) \ GUANYLYL CYCLASE ACTI
  • YC-1
  • LIFICIGUAT
  • 3-(5'-HYDROXYMETHYL-2'-FURYL)-1-BENZYLINDAZOLE
  • 5-[1-(PHENYLMETHYL)-1H-INDAZOL-3-YL]-2-FURANMETHANOL
  • Lificiguat(YC-1)
  • 1-benzyl-3-(5-hydroxymethyl-furan-2-yl)indazole
  • 1-Benzyl-3-(5-hydroxymethylfur-2-yl)indazole
  • YC 1 (pharMaceutical)
  • (5-(1-Benzyl-1H-indazol-3-yl)furan-2-yl)Methanol
  • Nsc728165
  • 2-Furanmethanol, 5-[1-(phenylmethyl)-1H-indazol-3-yl]-